Oliver Howes, Shubulade Smith. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Alendronate/therapeutic useAntipsychotic Agents/adverse effectsBone Diseases, Metabolic/chemically inducedBone Diseases, Metabolic/drug therapyFemaleHaloperidol/adverse effectsHumansMiddle AgedSchizophrenia, Paranoid/drug therapyTrifluoperazine/adverse effects
Substances: See more » Antipsychotic AgentsTrifluoperazineHaloperidolAlendronate
Year: 2004 PMID: 15056528 DOI: 10.1176/appi.ajp.161.4.756
Source DB: PubMed Journal: Am J Psychiatry ISSN: 0002-953X Impact factor: 18.112